Search 90 products by drug, renal measure or dialysis term. Each result identifies the formulation, the label used and the limits of its renal guidance.
Clinical renal category or population named in the cited section
Renal action or finding
In severe renal impairment, start at 12.5 mg/day. Titrate in 12.5 mg/day steps at weekly or longer intervals as indicated. Maximum daily doses are 50 mg for major depression or panic disorder, 37.5 mg for social anxiety disorder and 25 mg for PMDD.
Limits and monitoring
Confirm the indication and release form before applying a ceiling. Review the PMDD dosing schedule separately.
Clinical renal category or population named in the cited section
Renal action or finding
In renal impairment, use with caution and maintain hydration before, during and after bowel preparation. Consider pre-dose and post-colonoscopy electrolytes, creatinine and BUN.
Limits and monitoring
Review diuretics, ACE inhibitors, ARBs and NSAIDs that can increase risk of renal injury. This source gives monitoring guidance rather than a renal dose table.
Withhold if CrCl is below 45 mL/min. Recheck CrCl before each dose. At 45-79, avoid ibuprofen during the two days before treatment, treatment day and two days afterward.
Limits and monitoring
If ibuprofen cannot be withheld, increase monitoring for marrow suppression, renal injury and GI toxicity.
The U.S. labeling directs withholding below CrCl 45. The dated Ontario monograph instructs discontinuation below that threshold. Verify the applicable treatment protocol before deciding whether treatment may resume.
DailyMed SPL version 59, effective 2023-05-19; posted Jun 28, 2023 | Selected sections checked 2026-11-07. Independent clinical review pending.
At eGFR 15-29, limit the total to 15 mg per day. Avoid use below 15 or in dialysis-dependent ESRD.
Limits and monitoring
The cutoff uses mL/min/1.73 m2. Apply it only to the specified phentermine product. The labeled tablet contains 37.5 mg; verify an available strength that can deliver the prescribed renal dose.
eGFR, mL/min as printed in the dosage subsection; indexing not specified there
Renal action or finding
At eGFR 15-29 mL/min: reduce 200 mg daily to 100 mg daily. For other current doses, lower by 50 mg daily; discontinue if already taking 50 mg daily. At 30-89 there is no renal change.
Limits and monitoring
Use the current dose and the eGFR units as printed in the label. The selected bands do not establish a dialysis regimen.
BC Cancer specifies a renal weight-based regimen at CrCl 20-50 and provides no dose below 20 or on dialysis. Check the U.S. label and local transplant protocol separately.
This summary uses the identified dated label. Verify the current label for this presentation before applying the regimen.
Renal measure
Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Renal action or finding
At CrCl 30-50 mL/min, start with 0.375 mg every other day. After one week, consider daily dosing according to response and tolerance. Further increases are by 0.375 mg at intervals of at least one week, up to 2.25 mg/day.
Limits and monitoring
ER use is not recommended below 30 mL/min or on hemodialysis. Confirm the release form before prescribing.
